Condition: Cyclic Neutropenia · Congenital Neutropenia · Neutropenia · Sponsor: University of Washington
The objective of the Serial Blood Count Study is to determine the utility of home monitoring of white blood cell (WBC) and absolute neutrophil counts (ANC) to diagnose cyclic neutropenia and distinguish between cyclic and severe congenital neutropenia (SCN). A new home monitoring device called Athelas One was granted an FDA 510K Class 2 clearance for evaluation of white blood count (WBC) and absolute neutrophil count (ANC). The investigators believe this device provides a unique and extremely valuable opportunity to for diagnosis of these diseases.
This description comes directly from the study's public registry record.
Audrey Anna Bolyard, RN, BSN · 206-543-7218 · bolyard@uw.edu
David C. Dale, MD · 206-543-7215 · dcdale@uw.edu
Always discuss trial participation with your own doctor first.
| University of Washington Medical Center - Montlake | Seattle, Washington, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07066085